The conversation delves into the challenges of early cancer detection, highlighting the inadequacies of current technologies. Azra emphasizes the importance of understanding the triggers for abnormal cell behavior and discusses advancements in detecting cell-free DNA, which can reveal information about potential cancers. Despite promising developments, the accuracy of these tests remains limited, particularly in early-stage cancers.
